Related Experiment Videos
Angiogenic factors in endometriosis
Robert N Taylor1, Dan I Lebovic, Michael D Mueller
1Center for Reproductive Sciences, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 94143-0556, USA. rtaylor@socrates.ucsf.edu
Annals of the New York Academy of Sciences
|April 13, 2002
Summary
Endometriosis implants need new blood vessels to grow, similar to tumors. Targeting the factors that promote this blood vessel growth in the pelvic environment may offer new endometriosis treatments.
Area of Science:
- Reproductive biology
- Vascular biology
- Gynecology
Background:
- Endometriotic implants, like tumors, depend on neovascularization for growth and invasion.
- The peritoneal cavity offers a proangiogenic environment conducive to lesion establishment.
- Despite retrograde menstruation being common, endometriosis affects only about 10% of women.
Purpose of the Study:
- To review the key molecular factors driving angiogenesis in endometriosis.
- To explore the potential of targeting angiogenic pathways for endometriosis therapy.
Main Methods:
- Literature review of cytokines, growth factors, steroid hormones, and eicosanoids involved in endometriosis angiogenesis.
- Analysis of the peritoneal environment's role in promoting neovascularization.
Main Results:
- Identified major proangiogenic factors (cytokines, growth factors, hormones, eicosanoids) crucial for endometriosis.
- Highlighted the peritoneal milieu's significant contribution to lesion vascularization.
Conclusions:
- Understanding the angiogenic mechanisms in endometriosis is critical.
- Interfering with peritoneal angiogenic principles presents novel therapeutic strategies for pelvic endometriosis prevention and treatment.